Vir Biotechnology (VIR) Operating Margin (2018 - 2025)
Vir Biotechnology (VIR) has disclosed Operating Margin for 8 consecutive years, with 74.79% as the latest value for Q4 2025.
- Quarterly Operating Margin rose 87195.0% to 74.79% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 699.18% through Dec 2025, up 14531.0% year-over-year, with the annual reading at 699.18% for FY2025, 9210.0% up from the prior year.
- Operating Margin hit 74.79% in Q4 2025 for Vir Biotechnology, up from 72267.92% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 82.26% in Q1 2022 to a low of 72267.92% in Q3 2025.
- Historically, Operating Margin has averaged 6258.75% across 5 years, with a median of 691.23% in 2022.
- Biggest five-year swings in Operating Margin: skyrocketed 811025bps in 2022 and later crashed -6254926bps in 2025.
- Year by year, Operating Margin stood at 70.35% in 2021, then plummeted by -533bps to 304.6% in 2022, then tumbled by -172bps to 828.12% in 2023, then dropped by -14bps to 946.74% in 2024, then soared by 92bps to 74.79% in 2025.
- Business Quant data shows Operating Margin for VIR at 74.79% in Q4 2025, 72267.92% in Q3 2025, and 9754.28% in Q2 2025.